Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 2.37Close
$ 1.1 - $ 6.45 52-Week Range
Ticker Information
Ticker
CCCCCompany Name
C4 THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQC4 THERAPEUTICS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CCCC - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 0 | 0% | $ 34.24M |
| 3/31/2025 | $ 0 | 0% | $ 39.78M |
| 12/31/2024 | $ 0 | 0% | $ 35.58M |
| 9/30/2024 | $ 0 | 0% | $ 33.67M |
| 6/30/2024 | $ 167K | 0.57% | $ 29.38M |
| 3/31/2024 | $ 767K | 3.83% | $ 20.04M |
| 12/31/2023 | $ 1.37M | 6.61% | $ 20.76M |
| 9/30/2023 | $ 1.97M | 9.7% | $ 20.35M |
| 6/30/2023 | $ 2.36M | 14.73% | $ 16.03M |
| 3/31/2023 | $ 2.29M | 8.44% | $ 27.2M |
Key Performance Insights, Last 5 Years
- C4 THERAPEUTICS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 3.7%.
- Over the past 5 years, C4 THERAPEUTICS INC's average Int. Exp. % has been 4.88%.
- The median Int. Exp. % for C4 THERAPEUTICS INC during this period was 4.55%
- C4 THERAPEUTICS INC reached its highest Int. Exp. % over the past 5 years at 14.73%.
- The lowest Int. Exp. % recorded by C4 THERAPEUTICS INC in the same timeframe 0%
C4 THERAPEUTICS INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for C4 THERAPEUTICS INC is calculated as follows: Int. Exp. [ $ 1.23M ] / Revenues [ $ 33.2M ]
(=) Int. Exp. % [ 3.7% ] CCCC - Interest Expense Margin, Last 5 years
0%
Minimum
Sep 30, 2024
14.73%
Maximum
Jun 30, 2023
4.88%
Average
4.55%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.49% |
| average | 1.63% |
| median | 0.79% |
| std | 2.2% |